Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

EGX:CPCI Balance Sheet

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	239.83	171.22	168.28	139.38	111.87	131.76
Short-Term Investments	-	-	-	-	-	15
Cash & Short-Term Investments	239.83	171.22	168.28	139.38	111.87	146.76
Cash Growth	30.21%	1.74%	20.73%	24.59%	-23.77%	78.17%
Accounts Receivable	752.94	554.09	320.85	328.89	427.53	440.54
Other Receivables	0.15	52.48	58.7	0.35	50.33	45.53
Receivables	783.77	625.83	392.07	356.8	509.83	487.47
Inventory	532.13	591.46	465.59	401.77	333.41	281.22
Prepaid Expenses	0.41	3.8	0.26	0.25	-	-
Other Current Assets	341.31	66.69	30.89	89.72	-	-
Total Current Assets	1,897	1,459	1,057	987.92	955.11	915.46
Property, Plant & Equipment	587.17	562.56	453.82	249.24	211.12	150.41
Long-Term Investments	4.93	4.93	4.16	2.6	2.6	2.6
Other Intangible Assets	0.01	0.01	0.03	0.04	0.06	-
Other Long-Term Assets	-	-	0	-	-	-
Total Assets	2,490	2,026	1,515	1,240	1,169	1,068
Accounts Payable	815.12	435.55	237.1	224.39	142.9	235.93
Accrued Expenses	26.68	19.06	20.18	14.42	-	-
Short-Term Debt	0	22.99	-	56.66	-	-
Current Portion of Long-Term Debt	33.33	40	36.67	-	-	-
Current Income Taxes Payable	39.48	120.14	61.62	29.36	48.13	38.2
Other Current Liabilities	217.9	160.19	113.68	122.19	118.76	84.03
Total Current Liabilities	1,133	797.91	469.25	447.02	309.8	358.16
Long-Term Debt	123.33	123.33	163.33	68.76	-	-
Long-Term Leases	33.21	35.46	37.53	38.85	58.36	-
Long-Term Deferred Tax Liabilities	23.28	23.28	12.49	4.87	6.8	6.58
Other Long-Term Liabilities	0	0	0	-	-	-
Total Liabilities	1,312	979.99	682.6	559.5	374.95	364.74
Common Stock	149.34	149.34	149.34	149.34	149.34	149.34
Retained Earnings	888.57	757.84	543.76	383.26	488.51	398.33
Comprehensive Income & Other	139.32	139.32	139.39	147.7	156.09	156.06
Shareholders' Equity	1,177	1,047	832.49	680.31	793.94	703.73
Total Liabilities & Equity	2,490	2,026	1,515	1,240	1,169	1,068
Total Debt	189.87	221.78	237.53	164.27	58.36	-
Net Cash (Debt)	49.95	-50.57	-69.25	-24.88	53.52	146.76
Net Cash Growth	-	-	-	-	-63.53%	79.29%
Net Cash Per Share	3.34	-3.39	-4.64	-1.67	3.58	9.83
Filing Date Shares Outstanding	14.93	14.93	14.93	14.93	14.93	14.93
Total Common Shares Outstanding	14.93	14.93	14.93	14.93	14.93	14.93
Working Capital	764.94	661.08	587.84	540.89	645.31	557.29
Book Value Per Share	78.83	70.07	55.74	45.55	53.16	47.12
Tangible Book Value	1,177	1,046	832.46	680.26	793.88	703.73
Tangible Book Value Per Share	78.83	70.07	55.74	45.55	53.16	47.12
Land	0.4	0.4	-	0.4	0.4	0.4
Buildings	151.46	151.31	-	53.43	53.42	51.12
Machinery	549.84	545.75	-	291.46	250.9	244.46
Construction In Progress	158.1	128.61	212.7	114.11	81.88	75.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.